ITFI20110120A1 - METHOD AND KIT FOR DIAGNOSTICS IN VITRO OF ADVERSE REACTIONS "DELAYED TYPE" TO DRUGS. - Google Patents

METHOD AND KIT FOR DIAGNOSTICS IN VITRO OF ADVERSE REACTIONS "DELAYED TYPE" TO DRUGS.

Info

Publication number
ITFI20110120A1
ITFI20110120A1 IT000120A ITFI20110120A ITFI20110120A1 IT FI20110120 A1 ITFI20110120 A1 IT FI20110120A1 IT 000120 A IT000120 A IT 000120A IT FI20110120 A ITFI20110120 A IT FI20110120A IT FI20110120 A1 ITFI20110120 A1 IT FI20110120A1
Authority
IT
Italy
Prior art keywords
diagnostics
vitro
drugs
kit
adverse reactions
Prior art date
Application number
IT000120A
Other languages
Italian (it)
Inventor
Massimo Caruso
Giuseppe Pietro Luigi Maria Di
Giovanni Tringali
Original Assignee
Irma Istituto Ricerca Medica Ed Amb Ientale S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Irma Istituto Ricerca Medica Ed Amb Ientale S R L filed Critical Irma Istituto Ricerca Medica Ed Amb Ientale S R L
Priority to IT000120A priority Critical patent/ITFI20110120A1/en
Publication of ITFI20110120A1 publication Critical patent/ITFI20110120A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
IT000120A 2011-06-13 2011-06-13 METHOD AND KIT FOR DIAGNOSTICS IN VITRO OF ADVERSE REACTIONS "DELAYED TYPE" TO DRUGS. ITFI20110120A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT000120A ITFI20110120A1 (en) 2011-06-13 2011-06-13 METHOD AND KIT FOR DIAGNOSTICS IN VITRO OF ADVERSE REACTIONS "DELAYED TYPE" TO DRUGS.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000120A ITFI20110120A1 (en) 2011-06-13 2011-06-13 METHOD AND KIT FOR DIAGNOSTICS IN VITRO OF ADVERSE REACTIONS "DELAYED TYPE" TO DRUGS.

Publications (1)

Publication Number Publication Date
ITFI20110120A1 true ITFI20110120A1 (en) 2012-12-14

Family

ID=44555074

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000120A ITFI20110120A1 (en) 2011-06-13 2011-06-13 METHOD AND KIT FOR DIAGNOSTICS IN VITRO OF ADVERSE REACTIONS "DELAYED TYPE" TO DRUGS.

Country Status (1)

Country Link
IT (1) ITFI20110120A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004096848A2 (en) * 2003-04-29 2004-11-11 Genentech, Inc. Novel composition and methods for the treatment of immune disorders
WO2005015207A2 (en) * 2003-08-05 2005-02-17 Istituto Nazionale Per Le Malattie Infettive 'lazzaro Spallanzani' Irccs Method and diagnostic tests based on flow cytometric analysis of antigen-specific t lymphocytes
US20070185025A1 (en) * 2005-09-11 2007-08-09 The Trustees Of Columbia University In The City Of New York Filoviral immunosuppressive peptides and uses thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004096848A2 (en) * 2003-04-29 2004-11-11 Genentech, Inc. Novel composition and methods for the treatment of immune disorders
WO2005015207A2 (en) * 2003-08-05 2005-02-17 Istituto Nazionale Per Le Malattie Infettive 'lazzaro Spallanzani' Irccs Method and diagnostic tests based on flow cytometric analysis of antigen-specific t lymphocytes
US20070185025A1 (en) * 2005-09-11 2007-08-09 The Trustees Of Columbia University In The City Of New York Filoviral immunosuppressive peptides and uses thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
IMMUNOTECH: "Allergenicity Kit, Cellular Analysis of Allergy", 13 May 2004 (2004-05-13), pages 1-12, 89 - 94, XP002663575, Retrieved from the Internet <URL:http://www.bc-cytometry.com/information/pdf/A17116_Allergenicity_Kit.pdf> [retrieved on 20111115] *

Similar Documents

Publication Publication Date Title
IL265707A (en) Pharmaceutical compositions comprising human antibodies to pcsk9
HK1247254A1 (en) Methods and compositions for nucleic acid sequencing
EP3460064B8 (en) Efficient protein expression in vivo using modified rna (mod-rna)
IL231282A0 (en) Antibodies to pcsk9 and uses thereof
IL228001B (en) Antibodies to cd70
BR112014005744A2 (en) glucagon-like-2 peptide compositions and methods for their production and use
DK3050972T3 (en) PROCEDURES FOR THE PREPARATION OF EICOSAPENTAIC ACID IN THRAUSTOCHYTRIDES
BR112013019520A2 (en) method for the production of 2,3-butanediol by fermentation
EP2676142A4 (en) Methods and compositions relating to coagulation assays
BR112013014103A2 (en) method to produce an l-amino acid
CO6842021A2 (en) Epoxieicosatrienoic acid analogs and methods for making and using them
BR112013023465A2 (en) method to produce l-cysteine
AP3526A (en) Methods and compositions for increased plant yield
EP2773875A4 (en) Improvements in, or relating to, fasteners
BR112013033246A2 (en) in vitro cardiovascular model
EP2785736A4 (en) Assays, antibodies, immunogens and compositions related to 5-fu
EP2678339A4 (en) Methods and compositions for treating -thalassemia and sickle cell disease
HK1197069A1 (en) Methods for the synthesis and purification of deoxycholic acid
EP2699672A4 (en) Method to produce virus in cultured cells
EP2750688A4 (en) Methods and compositions for promoting glucose homeostasis
FI20115409A (en) Fasteners
ITFI20110120A1 (en) METHOD AND KIT FOR DIAGNOSTICS IN VITRO OF ADVERSE REACTIONS &#34;DELAYED TYPE&#34; TO DRUGS.
SM201000062A (en) Process for the preparation of gabapentin
EP2750706A4 (en) 2-hydroxyhippuric acid analogs, and methods for their synthesis and use
BR112012019774A2 (en) method to produce l-amino acid